Nindhana Paranthaman
Executive Medical Director of Clinical Development
Nindhana Paranthaman is an executive medical director of clinical development at Summit Therapeutics. Previously, she held multiple roles of increasing responsibility at Exelixis, Genentech, Amgen and Bristol Myers Squibb. She has a proven track record in drug development and commercialization with several first-in-class therapies that have shifted the treatment paradigm for cancer and autoimmune disease. Nindhana holds a medical degree from Sri Ramachandra Institute of Higher Education and Research and an MBA from The Johns Hopkins University Carey Business School. She is also an active speaker, advisor and DEI advocate for the global biotech community.